Evorpacept (ALX-148)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Evorpacept (ALX-148), covering 2025-10-16 to 2025-10-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer [Phase 1, Phase 2]